Results 241 to 250 of about 326,057 (335)

SHORT-CHAIN FATTY ACID-PRODUCING GUT MICROBIOTA: DYNAMICS AND IMPACT ON INTESTINAL PERMEABILITY AND CLINICAL OUTCOMES DURING ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION

Alexandre Soares Ferreira, David Álvarez, Larissa da Silva Souza, Luiz Fernando Almeida Machado, Nuno Silva, João Victor Piccolo Feliciano, Iago Colturato, George Maurício Navarro Barros, Phillip Scheinberg, Gislane Lelis Vilela de Oliveira   +9 more
openalex   +1 more source

Ecdysone-mediated intestinal growth contributes to microbiota-driven developmental plasticity under malnutrition [PDF]

Longwei Bai, François Leulier, Longwei Bai, Stéphanie Bellemin, Élodie Guillemot, Maura Strigini, Benjamin Gillet   +6 more
openalex   +1 more source

RORγt‐APCs: The New Masters of Oral Tolerance

Barrier Immunity, EarlyView.
ABSTRACT Oral tolerance is defined by the hypo‐responsiveness of our body to fed antigens, and its failure can lead to immune‐mediated diseases, such as allergy, chronic inflammation and autoimmune diseases. Decades of research have demonstrated that antigen‐presenting cells (APCs) promote oral tolerance by inducing regulatory T cells (Tregs) and/or ...
Thierry Gauthier, WanJun Chen
wiley   +1 more source

Microcystin-LR-Induced Oxidative Stress, Transcriptome Changes, Intestinal Microbiota, and Histopathology in Rana chensinensis Tadpoles. [PDF]

Animals (Basel)
Wang Y, Wang B, He Z, Chen J, Liu C, Wang Z, Irfan M, Zhang L.   +7 more
europepmc   +1 more source

Composition of the intestinal microbiota of female Wistar rats with chemically induced breast cancer and under various therapies

Александр Федорович Повещенко, Лариса Вячеславовна Медведева, Валерия Николаевна Черкас, Алексей Васильевич Кабаков, Олег Васильевич Казаков, Александра Андреевна Шипова, Екатерина Юрьевна Кондратюк, Наталья Романовна Бодрова, Геннадий Владимирович Васильев   +8 more
openalex   +2 more sources

Gut microbiota‐related modulation of immune mechanisms in post‐infarction remodelling and heart failure

ESC Heart Failure, Volume 12, Issue 2, Page 942-954, April 2025.
Abstract The immune system has long been recognized as a key driver in the progression of heart failure (HF). However, clinical trials targeting immune effectors have consistently failed to improve patient outcome across different HF aetiologies. The activation of the immune system in HF is complex, involving a broad network of pro‐inflammatory and ...
Johann Roessler, Friederike Zimmermann, Bettina Heidecker, Ulf Landmesser, Arash Haghikia   +4 more
wiley   +1 more source

Patterns and influencing factors of intestinal microbiota from different groupers. [PDF]

Anim Microbiome
Song W, Chen C, Du X, Zhang R, Zhao J.
europepmc   +1 more source

Comparação da microbiota intestinal em modelos animais de doença hepática esteatótica alcoólica e metabólica

Perlin, Cássio Marques, Longo, Larisse, Thoen, Rutiane Ullmann, Cruz, Carolina Uribe, Álvares-da-Silva, Mário Reis   +4 more
openalex   +1 more source

Exploring intestinal microbiota in pigs: validation and application of a novel non-invasive sampling device

Inés García Viñado
openalex   +2 more sources

Meta‐analysis of sotagliflozin, a dual sodium‐glucose‐cotransporter 1/2 inhibitor, for heart failure in type 2 diabetes

ESC Heart Failure, Volume 12, Issue 2, Page 968-979, April 2025.
Abstract Sodium‐glucose co‐transporters (SGLTs) mediate sodium and glucose transport across cell membranes. SGLT2 inhibitors have a recognized place within heart failure (HF) guidelines. We evaluated the effect of sotagliflozin on HF and cardiovascular outcomes in participants with type 2 diabetes. Scopus, Medline, Embase and Central were searched from
Maria Anna Bantounou, Panagiotis Sardellis, Josip Plascevic, Ribeya Awaes‐Mahmood, Justyna Kaczmarek, Daniel Black Boada, Rosa Thuemmler, Sam Philip   +7 more
wiley   +1 more source